Skip to main content
Caplight Logo









PlusTerveys

PlusTerveys

Private
HelsinkiHealthcare & Life Scienceshttps://www.plusterveys.fi/

Last Round

Growth Equity

May 28, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PlusTerveys is a Finnish private healthcare company that provides comprehensive dental and mental health services through a nationwide network of clinics.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Telemedicine, Patient Engagement

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

private healthcaredental careoccupational healthcareprivate dentistphysiotherapyoccupational healthphysical therapyprivate clinicGPgeneral practitionerhealthcare providermedical specialistprivate medical serviceshealth check-up

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PlusTerveys Comparables

Compare PlusTerveys with similar companies based on industry and business-model similarity.

PlusTerveys comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lääkärikeskus Aava
91%
Pihlajalinna Oyj
79%
Terveystalo
79%

PlusTerveys Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityMay 28, 2026

Key People

Founding team and executive leadership

Joni Aaltonen

Group CEO

Executive Team

Seija Nurmi

Chief Operating Officer, Development Manager

Executive Team

PlusTerveys Investors

Notable investors and investment history

PlusTerveys investors
InvestorRounds
Voland PartnersGrowth Equity
Varma Mutual Pension Insurance CompanyGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 28, 2026

    Raised Growth Equity round with Varma Mutual Pension Insurance Company and Voland Partners.

  • Nov 11, 2025

    Monthly visitors grew 130% MoM, reaching 38.4K.

PlusTerveys Filings

Explore SEC and related filing metadata, where available.

PlusTerveys filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PlusTerveys's valuation, stock price, and market status.

Is PlusTerveys a public or private company?

PlusTerveys is a private company.

What is the current stock price of PlusTerveys?

PlusTerveys is a private company with no public stock price. Caplight tracks PlusTerveys's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is PlusTerveys worth (valuation)?

Valuation information for PlusTerveys is not publicly available.

Can I buy PlusTerveys stock?

PlusTerveys shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PlusTerveys's last funding round?

PlusTerveys's most recent funding round was Growth Equity on May 28, 2026.

Who are the main investors in PlusTerveys?

Key investors in PlusTerveys include Voland Partners, Varma Mutual Pension Insurance Company.

Will PlusTerveys IPO soon?

No public IPO plans have been announced for PlusTerveys.

How can I track PlusTerveys secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PlusTerveys's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHelsinki
Employee Range241
Year Founded1978
Last FundingMay 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?